Study to Evaluate the Pharmacokinetics, Safety and Tolerability of GSK557296 in Healthy Women Volunteers After Single and Repeat Dosing
Clinical trial NCT01669083 · COMPLETED
Trial details
- NCT number
- NCT01669083
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-16
- Primary completion
- 2013-03-09
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.